<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01237353</url>
  </required_header>
  <id_info>
    <org_study_id>GastricpH-6264</org_study_id>
    <nct_id>NCT01237353</nct_id>
  </id_info>
  <brief_title>Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers</brief_title>
  <official_title>Pilot Study Evaluating Gastric Re-acidification Using Betaine Hydrochloride in Healthy Volunteers With Pharmacologically Induced Hypochlorhydria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators will test a nutritional supplement called betaine
      hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers
      who have decreased stomach acid because they take a medicine called rabeprazole.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will evaluate the extent and time course of gastric re-acidification after oral
      betaine HCl in healthy volunteers with pharmacologically-induced hypochlorhydria. After
      betaine HCl dose, gastric pH will be continuously monitored for 2 hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Gastric pH After Administration of Betaine Hydrochloride (HCl)</measure>
    <time_frame>30 minutes</time_frame>
    <description>Gastric pH levels monitored with a Heidelberg pH capsule (HC) which sends real-time signals to a computer system that visually plots intestinal pH on a minute-by-minute basis. When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of Gastric pH Status</measure>
    <time_frame>2 hours after dose of betaine HCl</time_frame>
    <description>When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Pharmacodynamic</condition>
  <arm_group>
    <arm_group_label>betaine hydrochloride and rabeprazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>betaine hydrochloride</intervention_name>
    <description>betaine hydrochloride 1500mg po x 1 on day 5</description>
    <arm_group_label>betaine hydrochloride and rabeprazole</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rabeprazole</intervention_name>
    <description>rabeprazole po daily x 5 days</description>
    <arm_group_label>betaine hydrochloride and rabeprazole</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adult with no active medical problems or significant chronic diseases as
             determined by the study doctor based on history, physical exam;

          -  BMI between 18.5 - 35 kg/m2;

          -  Taking no medications 2 weeks before and during the study enrollment, including drugs
             of abuse, prescription or OTC medications (except acetaminophen);

          -  Subjects must be able to maintain adequate birth control during the study independent
             of hormonal contraceptive use;

          -  Be able to provide written informed consent and comply with requirements of the study;

          -  Avoid eating grapefruit and drinking grapefruit juice from 7 days before the first
             study day until completion of the entire study;

          -  Abstinence from alcoholic beverages, caffeinated beverages and orange juice from 6pm
             the night before a study day until completion of that study day;

          -  Fast from food and beverages at least 8 hours prior to the study day;

          -  Be able to read, speak and understand English

        Exclusion Criteria:

          -  Subjects with a history of gastrointestinal disease including gastroesophageal reflux
             disease, gastritis, peptic ulcer disease or dyspepsia.

          -  Subjects with a fasting gastric pH of &gt; 4 (i.e. hypochlorhydria)

          -  Subjects with history of dysphagia, achalasia, or difficulty swallowing capsules,
             tablets or pills.

          -  Subjects on prescription or chronic over-the counter medications (including hormonal
             contraceptives);

          -  Subjects with known allergy to study interventions;

          -  Subjects who smoke tobacco;

          -  Subjects with ongoing alcohol or illegal drug use;

          -  Subjects who are pregnant, lactating or attempting to conceive;

          -  Subjects unable to maintain adequate birth control during the study;

          -  Subjects unable to follow protocol instructions or protocol criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leslie Benet, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <results_first_submitted>May 14, 2013</results_first_submitted>
  <results_first_submitted_qc>May 14, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 2, 2013</results_first_posted>
  <last_update_submitted>May 14, 2013</last_update_submitted>
  <last_update_submitted_qc>May 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rabeprazole</mesh_term>
    <mesh_term>Betaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy volunteers were recruited to one clinical site in the U.S.</recruitment_details>
      <pre_assignment_details>Hypochlorhydria was induced through the administration of 20mg oral rabeprazole twice daily with food for four days prior to study day</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Betaine Hydrochloride and Rabeprazole</title>
          <description>betaine hydrochloride : betaine hydrochloride 1500mg po x 1 on day 5
Rabeprazole : rabeprazole po daily x 5 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Betaine Hydrochloride and Rabeprazole</title>
          <description>betaine hydrochloride : betaine hydrochloride 1500mg po x 1 on day 5
Rabeprazole : rabeprazole po daily x 5 days</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.83" lower_limit="25" upper_limit="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Gastric pH After Administration of Betaine Hydrochloride (HCl)</title>
        <description>Gastric pH levels monitored with a Heidelberg pH capsule (HC) which sends real-time signals to a computer system that visually plots intestinal pH on a minute-by-minute basis. When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours.</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Betaine Hydrochloride and Rabeprazole</title>
            <description>betaine hydrochloride : betaine hydrochloride 1500mg po x 1 on day 5
Rabeprazole : rabeprazole po daily x 5 days</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Gastric pH After Administration of Betaine Hydrochloride (HCl)</title>
          <description>Gastric pH levels monitored with a Heidelberg pH capsule (HC) which sends real-time signals to a computer system that visually plots intestinal pH on a minute-by-minute basis. When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.54" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Gastric pH Status</title>
        <description>When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours</description>
        <time_frame>2 hours after dose of betaine HCl</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Betaine Hydrochloride and Rabeprazole</title>
            <description>betaine hydrochloride : betaine hydrochloride 1500mg po x 1 on day 5
Rabeprazole : rabeprazole po daily x 5 days</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Gastric pH Status</title>
          <description>When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mean time to pH &lt;3.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean minutes of pH &lt; 3.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.5" spread="32.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean minutes of pH &lt; 4.0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.8" spread="30.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 hours after betaine HCl dose, or by report of subject</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Betaine Hydrochloride and Rabeprazole</title>
          <description>betaine hydrochloride : betaine hydrochloride 1500mg po x 1 on day 5
Rabeprazole : rabeprazole po daily x 5 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Leslie Benet</name_or_title>
      <organization>University of California San Francisco</organization>
      <phone>415-476-3853</phone>
      <email>leslie.benet@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

